GlassScriptPhysician profile
Laurie A Hughell
NPI 1245241116
$8,936.69
in general payments reported to CMS, 2019-2025
13 companies · $5,996 in 2025
The $5,996 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $799 · 2022: $1,113 · 2023: $359 · 2024: $670 · 2025: $5,996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,940 · Food and Beverage: $1,909 · Travel and Lodging: $1,152 · Education: $23.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,940.00 |
| Food and Beverage | $1,908.80 |
| Travel and Lodging | $1,152.08 |
| Education | $23.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $5,710.35 | 2022-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $804.14 | 2022-2024 | Simponi Aria, Tremfya |
| Horizon Therapeutics Plc | $625.54 | 2021-2022 | |
| Amgen INC. | $448.78 | 2023-2025 | Evenity, Tavneos |
| Astrazeneca Pharmaceuticals LP | $316.80 | 2022-2024 | Saphnelo |
| Novartis Pharmaceuticals Corporation | $302.57 | 2022-2025 | |
| Abbvie INC. | $207.75 | 2023-2025 | |
| Glaxosmithkline, LLC. | $141.44 | 2023-2025 | Benlysta |
| Aurinia Pharma U.S., INC. | $132.89 | 2021 | |
| Cardinal Health 110 LLC | $100.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $85.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.04 | 2023 | Ofev |
| Novo Nordisk INC | $21.39 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurie Hughell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.